Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

Recent & Breaking News (TSXV:VM)

InvestmentPitch Media video discusses the ruling by the D.C. Circuit Court of Appeals qualifying Voyageur Pharmaceuticals’ (TSXV:VM) products as devices

John Ballem  April 21, 2021

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs - Video Available on Investmentpitch.com

Newsfile April 21, 2021

Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out

TheNewsWire April 20, 2021

Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing

TheNewsWire April 13, 2021

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications - Video Available on Investmentpitch.com

Newsfile April 7, 2021

Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast

TheNewsWire April 5, 2021

Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options

TheNewsWire April 5, 2021

Voyageur Pharmaceuticals Ltd. Signs Manufacturing Agreement With Alberta Veterinarian Laboratories Ltd. for Barium Radiographic Contrast Production

TheNewsWire March 23, 2021

Voyageur Pharmaceuticals Ltd. Receives $209,764.05 from Exercise of Warrants and Options

TheNewsWire March 10, 2021

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.com

Newsfile February 17, 2021

Voyageur Pharmaceuticals Ltd. Announces Second Health Canada Approval and Issuance of Product License for HDXBa; Radiographic Barium Contrast

TheNewsWire February 16, 2021

Health Canada Approves Product License for Voyageur Solution

Stockhouse Editorial February 12, 2021

Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension

TheNewsWire February 12, 2021

Voyageur Pharmaceuticals Ltd. Announces Second and Final Closing of Private Placement and Future Director Retirement

TheNewsWire January 18, 2021

Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement and First Closing

TheNewsWire December 31, 2020

Voyageur Files Further Updated NI 43-101 Report on the Frances Creek Barite Project

TheNewsWire December 18, 2020

Solving a Critical Supply Problem for North American Pharmaceuticals

Stockhouse Editorial December 16, 2020

Voyageur Pharmaceuticals Ltd. Announces up to $600,000 Private Placement

TheNewsWire December 9, 2020

Voyageur Pharmaceuticals Ltd. Announces Signing LOI for Contract Manufacturing of Barium Radiographic Contrast Media with Alberta Veterinarian Laboratories Ltd.

TheNewsWire November 30, 2020

Voyageur Pharmaceuticals Ltd. Announces Withdrawal of Corporate Presentation and Update on the Fullerene Project

TheNewsWire November 18, 2020